MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

Clinical trial NCT06412497 · RECRUITING

Trial details

NCT number: NCT06412497
Sponsor: Masonic Cancer Center, University of Minnesota
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Aplastic Anemia Acquired Amegakaryocytic Thrombocytopenia Acquired Pure Red Cell Aplasia Paroxysmal Nocturnal Hemoglobinuria

Start date: 2024-06-05
Primary completion: 2035-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.